CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6
Centrosome
Mice, Knockout
0303 health sciences
Indoles
Tumor Suppressor Proteins
Acetylation
Histone Deacetylase 6
Hydroxamic Acids
Histone Deacetylases
Cell Line
Mice, Inbred C57BL
Mice
03 medical and health sciences
Mice, Inbred DBA
Tubulin
Sperm Motility
Animals
Humans
RNA Interference
Cilia
RNA, Small Interfering
Microtubule-Associated Proteins
DOI:
10.1038/cr.2014.136
Publication Date:
2014-10-24T10:50:37Z
AUTHORS (12)
ABSTRACT
Cilia are hair-like organelles extending from the cell surface with important sensory and motility functions. Ciliary defects can result in a wide range of human diseases known as ciliopathies. However, the molecular mechanisms controlling ciliogenesis remain poorly defined. Here we show that cylindromatosis (CYLD), a tumor suppressor protein harboring deubiquitinase activity, plays a critical role in the assembly of both primary and motile cilia in multiple organs. CYLD knockout mice exhibit polydactyly and various ciliary defects, such as failure in basal body anchorage and disorganization of basal bodies and axenomes. The ciliary function of CYLD is partially attributed to its deconjugation of the polyubiquitin chain from centrosomal protein of 70 kDa (Cep70), a requirement for Cep70 to interact with γ-tubulin and localize at the centrosome. In addition, CYLD-mediated inhibition of histone deacetylase 6 (HDAC6), which promotes tubulin acetylation, constitutes another mechanism for the ciliary function of CYLD. Small-molecule inhibitors of HDAC6 could partially rescue the ciliary defects in CYLD knockout mice. These findings highlight the importance of protein ubiquitination in the modulation of ciliogenesis, identify CYLD as a crucial regulator of this process, and suggest the involvement of CYLD deficiency in ciliopathies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (91)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....